Innovation
23 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,351 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 9 |
| 2024 | 13 |
| 2025 | 16 |
| 2026 | 2 |
Social engagement
Social engagement: 23.6K social following, 10 posts in the last 12 months — above the industry median.
Investor mix
17 investors on record; lead investors include SoftBank Vision Fund, Qiming, Cormorant Asset Management, DCVC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 59% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 35% |
Hiring activity
Hires periodically
14 roles tracked across 5 of the last 12 months
10 Jun 2026 · Vice President Analytical Development · Louisville
23 Feb 2026 · Senior Specialist, Clinical Supply Chain · Louisville
10 Feb 2026 · Associate Director, Clinical Scientist · Seattle
1 Feb 2026 · Senior Financial Analyst · Boulder
23 Jan 2026 · Director, CMC Regulatory · Seattle
Based on job postings tracked across public sources.
Recent activity
27 Apr 2026
Event
ASGCT Annual Meeting poster presentation for UBVV500
23 Mar 2026
Leadership hire
Board of Directors
14 Nov 2025
Recognition